We've merged with Palleos Healthcare to form a wide-reaching European CRO.
Find out more
OCT Clinical will be attending the prestigious 10th LSX World Congress. As the leading partnering, strategy, and investment event in Europe, the congress offers opportunities for networking, collaboration, and investment in the biopharma, medtech, and healthtech sectors.
Our team will be represented by our Head of Business Development, Anna Yanaeva, and we're looking forward to engaging with industry leaders, forging partnerships, and exploring innovative opportunities to advance medical research and improve patient outcomes.
Reach out to Anna at ayanaeva@oct-clinicaltrials.com to book a meeting with OCT Clinical Team to discuss your clinical trials options in Eastern Europe.
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.